Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries

OBJECTIVE: To estimate the changes in life expectancy and years of life lost in 2020 associated with the covid-19 pandemic. DESIGN: Time series analysis. SETTING: 37 upper-middle and high income countries or regions with reliable and complete mortality data. PARTICIPANTS: Annual all cause mortality...

Full description

Bibliographic Details
Published in:BMJ
Main Authors: Islam, Nazrul, Jdanov, Dmitri A, Shkolnikov, Vladimir M, Khunti, Kamlesh, Kawachi, Ichiro, White, Martin, Lewington, Sarah, Lacey, Ben
Format: Text
Language:English
Published: BMJ Publishing Group Ltd. 2021
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564739/
https://doi.org/10.1136/bmj-2021-066768
id ftpubmed:oai:pubmedcentral.nih.gov:8564739
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:8564739 2023-05-15T16:49:37+02:00 Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries Islam, Nazrul Jdanov, Dmitri A Shkolnikov, Vladimir M Khunti, Kamlesh Kawachi, Ichiro White, Martin Lewington, Sarah Lacey, Ben 2021-11-03 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564739/ https://doi.org/10.1136/bmj-2021-066768 en eng BMJ Publishing Group Ltd. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564739/ http://dx.doi.org/10.1136/bmj-2021-066768 © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . CC-BY BMJ Research Text 2021 ftpubmed https://doi.org/10.1136/bmj-2021-066768 2021-11-07T01:58:33Z OBJECTIVE: To estimate the changes in life expectancy and years of life lost in 2020 associated with the covid-19 pandemic. DESIGN: Time series analysis. SETTING: 37 upper-middle and high income countries or regions with reliable and complete mortality data. PARTICIPANTS: Annual all cause mortality data from the Human Mortality Database for 2005-20, harmonised and disaggregated by age and sex. MAIN OUTCOME MEASURES: Reduction in life expectancy was estimated as the difference between observed and expected life expectancy in 2020 using the Lee-Carter model. Excess years of life lost were estimated as the difference between the observed and expected years of life lost in 2020 using the World Health Organization standard life table. RESULTS: Reduction in life expectancy in men and women was observed in all the countries studied except New Zealand, Taiwan, and Norway, where there was a gain in life expectancy in 2020. No evidence was found of a change in life expectancy in Denmark, Iceland, and South Korea. The highest reduction in life expectancy was observed in Russia (men: −2.33, 95% confidence interval −2.50 to −2.17; women: −2.14, −2.25 to −2.03), the United States (men: −2.27, −2.39 to −2.15; women: −1.61, −1.70 to −1.51), Bulgaria (men: −1.96, −2.11 to −1.81; women: −1.37, −1.74 to −1.01), Lithuania (men: −1.83, −2.07 to −1.59; women: −1.21, −1.36 to −1.05), Chile (men: −1.64, −1.97 to −1.32; women: −0.88, −1.28 to −0.50), and Spain (men: −1.35, −1.53 to −1.18; women: −1.13, −1.37 to −0.90). Years of life lost in 2020 were higher than expected in all countries except Taiwan, New Zealand, Norway, Iceland, Denmark, and South Korea. In the remaining 31 countries, more than 222 million years of life were lost in 2020, which is 28.1 million (95% confidence interval 26.8m to 29.5m) years of life lost more than expected (17.3 million (16.8m to 17.8m) in men and 10.8 million (10.4m to 11.3m) in women). The highest excess years of life lost per 100 000 population were observed in Bulgaria (men: 7260, 95% confidence ... Text Iceland PubMed Central (PMC) New Zealand Norway BMJ e066768
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Research
spellingShingle Research
Islam, Nazrul
Jdanov, Dmitri A
Shkolnikov, Vladimir M
Khunti, Kamlesh
Kawachi, Ichiro
White, Martin
Lewington, Sarah
Lacey, Ben
Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries
topic_facet Research
description OBJECTIVE: To estimate the changes in life expectancy and years of life lost in 2020 associated with the covid-19 pandemic. DESIGN: Time series analysis. SETTING: 37 upper-middle and high income countries or regions with reliable and complete mortality data. PARTICIPANTS: Annual all cause mortality data from the Human Mortality Database for 2005-20, harmonised and disaggregated by age and sex. MAIN OUTCOME MEASURES: Reduction in life expectancy was estimated as the difference between observed and expected life expectancy in 2020 using the Lee-Carter model. Excess years of life lost were estimated as the difference between the observed and expected years of life lost in 2020 using the World Health Organization standard life table. RESULTS: Reduction in life expectancy in men and women was observed in all the countries studied except New Zealand, Taiwan, and Norway, where there was a gain in life expectancy in 2020. No evidence was found of a change in life expectancy in Denmark, Iceland, and South Korea. The highest reduction in life expectancy was observed in Russia (men: −2.33, 95% confidence interval −2.50 to −2.17; women: −2.14, −2.25 to −2.03), the United States (men: −2.27, −2.39 to −2.15; women: −1.61, −1.70 to −1.51), Bulgaria (men: −1.96, −2.11 to −1.81; women: −1.37, −1.74 to −1.01), Lithuania (men: −1.83, −2.07 to −1.59; women: −1.21, −1.36 to −1.05), Chile (men: −1.64, −1.97 to −1.32; women: −0.88, −1.28 to −0.50), and Spain (men: −1.35, −1.53 to −1.18; women: −1.13, −1.37 to −0.90). Years of life lost in 2020 were higher than expected in all countries except Taiwan, New Zealand, Norway, Iceland, Denmark, and South Korea. In the remaining 31 countries, more than 222 million years of life were lost in 2020, which is 28.1 million (95% confidence interval 26.8m to 29.5m) years of life lost more than expected (17.3 million (16.8m to 17.8m) in men and 10.8 million (10.4m to 11.3m) in women). The highest excess years of life lost per 100 000 population were observed in Bulgaria (men: 7260, 95% confidence ...
format Text
author Islam, Nazrul
Jdanov, Dmitri A
Shkolnikov, Vladimir M
Khunti, Kamlesh
Kawachi, Ichiro
White, Martin
Lewington, Sarah
Lacey, Ben
author_facet Islam, Nazrul
Jdanov, Dmitri A
Shkolnikov, Vladimir M
Khunti, Kamlesh
Kawachi, Ichiro
White, Martin
Lewington, Sarah
Lacey, Ben
author_sort Islam, Nazrul
title Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries
title_short Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries
title_full Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries
title_fullStr Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries
title_full_unstemmed Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries
title_sort effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries
publisher BMJ Publishing Group Ltd.
publishDate 2021
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564739/
https://doi.org/10.1136/bmj-2021-066768
geographic New Zealand
Norway
geographic_facet New Zealand
Norway
genre Iceland
genre_facet Iceland
op_source BMJ
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564739/
http://dx.doi.org/10.1136/bmj-2021-066768
op_rights © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
op_rightsnorm CC-BY
op_doi https://doi.org/10.1136/bmj-2021-066768
container_title BMJ
container_start_page e066768
_version_ 1766039763906723840